CHARGED ALPHATMFrontier AI stock research

STE · NYSE

STERIS plc

Medical Devices · United States

USD 211.690.3% daily changeQuote 2026-10-06 · USD
Market cap (USD)
US$20.64B
Trailing P/E
25.88x
Forward P/E
17.28x
Quarterly revenue growth
7.3%
Trailing net margin
13.3%
Indicated dividend yield
1.2%

Snapshot 2026-10-06 · Latest financial period 2026-06-30 · Yahoo Finance. Quotes may be delayed; reporting periods can differ.

Next earnings: 2026-11-04 (provider estimate, not issuer-confirmed).

Company background

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.

Company website

Q4 FY2026

Go beyond the headline.

STE Stock: EPS Misses Estimates — Q4 FY2026

Published 2026-05-12

Comparable businesses

STE peer comparison

Same business group first, then company size. Preferred market cap: 0.5–2x; extended range: one-third–3x. Outside that range, industry benchmarks are labeled separately and excluded from peer medians.

Comparison stocks

No suitable peers with fresh, comparable size data are available. We have not substituted unrelated companies.

Market metrics · missing or inapplicable values shown as —
MetricSTESTERIS plcSnapshot 2026-10-06Financial period: 2026-06-30
Market capMarket value, converted to USDUS$20.64B
Forward P/EProvider forward earnings estimate17.28x
EV / EBITDAEnterprise value / trailing EBITDA13.51x
Revenue growthLatest quarter vs prior-year quarter7.3%
Operating marginLatest reported quarter19.2%
Free cash flow yieldTrailing cash flow / market cap3.9%
Net debt / EBITDANet debt / trailing EBITDA0.95x
Debt / equityTotal debt / positive book equity0.28x
Trailing P/ETrailing twelve-month earnings25.88x
Price / bookPrice / positive book equity per share2.86x
EV / salesEnterprise value / trailing revenue3.67x
Earnings growthLatest quarter vs prior-year quarter14.0%
Gross marginTrailing twelve months44.4%
Net marginTrailing twelve months13.3%
Return on equityProvider trailing return; positive equity only11.4%
Free cash flow marginTrailing free cash flow / revenue13.2%
Dividend yieldIndicated annual dividend / price1.2%
Earnings payoutProvider trailing dividend payout30.8%
Current ratioCurrent assets / current liabilities1.91x
BetaProvider historical market sensitivity0.93

Choose a comparison stock

Search covered companies, or search all listed stocks.

Comparison methodology & limitations

Reviewed operating groups override broad sector classifications. Other companies are matched only within a sufficiently specific provider industry. Business mix, geography and accounting standards can still differ. Market caps are converted to USD using exchange rates captured during the snapshot refresh. Financial ratios that would mix currencies are omitted. Snapshots must be at most 14 days old and no more than seven days apart for automatic selection.

Peer medians require at least two valid similar-size peers for each metric. Negative earnings, nonpositive equity, missing data and irrelevant bank ratios are not presented as attractive valuations. A higher or lower number is not automatically a better investment. Financial statement periods are not calendar-aligned across companies.

Reported performance

Financial trends

Reporting period
Financial history
Chart style
Comparison stocks

Financial statements load separately from the research page.

Market context

Valuation & price history

Adjusted closing price

Price history

Price history loads separately.

Earnings-multiple scenario

Illustrative price = your earnings-per-share assumption × your P/E assumption. This is not a price target or a complete valuation model.

Starting assumptions, when available, use provider forward estimates as of 2026-10-06. Negative earnings require a different valuation method. This calculation omits balance-sheet, dilution and execution risks.

THE RESEARCH RECORD

Research history for STE

All available reporting periods
Q4 FY20262026-05-12

STE Stock: EPS Misses Estimates — Q4 FY2026

Presentation · 2026-05-12 · YouTube

Reported figures

Verify material figures against company filings. Market data and AI-assisted analysis may contain errors.